Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Germ Cell Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNo Longer AvailableNCT01838187
What this trial is testing

Expanded Access Protocol Using 131I-MIBG Therapy +/- Vorinostat for Refractory Neuroblastoma, Pheochromocytoma, or Paraganglioma

Who this might be right for
NeuroblastomaPheochromocytomaParaganglioma
Children's Hospital Medical Center, Cincinnati
Testing effectiveness (Phase 2)Active Not RecruitingNCT02574728
What this trial is testing

Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS Tumors

Who this might be right for
Cancer
Emory University 46
Early research (Phase 1)Not Yet RecruitingNCT07773454
What this trial is testing

Study of Zanzalintinib in Children and Adolescents With Relapsed or Refractory Solid Tumors

Who this might be right for
CancerPediatric Cancer
Exelixis 18
Testing effectiveness (Phase 2)Ended earlyNCT04023331
What this trial is testing

67Cu-SARTATE™ Peptide Receptor Radionuclide Therapy Administered to Pediatric Patients With High-Risk, Relapsed, Refractory Neuroblastoma

Who this might be right for
NeuroblastomaRelapsed NeuroblastomaRefractory Neuroblastoma
Clarity Pharmaceuticals Ltd 21
Early research (Phase 1)Study completedNCT01324479
What this trial is testing

Study of INC280 in Patients With c-MET Dependent Advanced Solid Tumors

Who this might be right for
Solid Tumors
Novartis Pharmaceuticals 131
Early research (Phase 1)Study completedNCT01682746
What this trial is testing

Photodynamic Therapy (PDT) for Recurrent Pediatric Brain Tumors

Who this might be right for
Brain Tumor, Recurrent
Harry T Whelan, MD 5
Testing effectiveness (Phase 2)Ended earlyNCT02332889
What this trial is testing

Phase I/II: Decitabine/Vaccine Therapy in Relapsed/Refractory Pediatric High Grade Gliomas/Medulloblastomas/CNS PNETs

Who this might be right for
GliomasMedulloblastomaNeuroectodermal Tumors, Primitive
University of Louisville 1
Early research (Phase 1)Looking for participantsNCT07087002
What this trial is testing

GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults

Who this might be right for
MedulloblastomaCentral Nervous System Embryonal TumorRefractory Medulloblastoma+7 more
Stanford University 18
Early research (Phase 1)Study completedNCT00667641
What this trial is testing

Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+6 more
University of Medicine and Dentistry of New Jersey 16
Testing effectiveness (Phase 2)Study completedNCT00795769
What this trial is testing

Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+101 more
Fred Hutchinson Cancer Center 49
Testing effectiveness (Phase 2)UnknownNCT04812002
What this trial is testing

Study of PD-1 Antibody and Bevacizumab in the Treatment of High-risk GTN After Combined Chemotherapy

Who this might be right for
Gestational Trophoblastic Neoplasia
Women's Hospital School Of Medicine Zhejiang University 20
Testing effectiveness (Phase 2)Ended earlyNCT01159067
What this trial is testing

Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload

Who this might be right for
Iron OverloadAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+99 more
City of Hope Medical Center 1
Early research (Phase 1)Study completedNCT02861222
What this trial is testing

Myocet® in Children With Relapsed or Refractory Non-brainstem Malignant Glioma

Who this might be right for
Malignant Glioma
Central Hospital, Nancy, France 13
Testing effectiveness (Phase 2)Active Not RecruitingNCT06056895
What this trial is testing

Triple Immune Checkpoint Inhibition for Advanced or Metastatic PD-(L)1 Refractory Merkel Cell Carcinoma

Who this might be right for
Unresectable Clinical Stage III Merkel Cell Carcinoma AJCC v8Clinical Stage IV Merkel Cell Carcinoma AJCC v8Merkel Cell Carcinoma
University of Washington 12
Testing effectiveness (Phase 2)Study completedNCT01466231
What this trial is testing

Everolimus in Refractory Testicular Germ Cell Cancer

Who this might be right for
Germ Cell Tumor
National Cancer Institute, Slovakia 15
Early research (Phase 1)Study completedNCT00644696
What this trial is testing

Study of Irinotecan and Bortezomib in Children With Recurrent/Refractory Neuroblastoma

Who this might be right for
Neuroblastoma
University of Michigan Rogel Cancer Center 18
Not applicableUnknownNCT02919046
What this trial is testing

Study Evaluating the Efficacy and Safety With CAR-T for Relapsed or Refractory Neuroblastoma in Children

Who this might be right for
Relapsed or Refractory Neuroblastoma
Sinobioway Cell Therapy Co., Ltd. 22
Early research (Phase 1)Ended earlyNCT04541225
What this trial is testing

Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors

Who this might be right for
GliomaGlioma, MalignantGlioma, Mixed+21 more
Nuvation Bio Inc. 74
Testing effectiveness (Phase 2)Study completedNCT01183897
What this trial is testing

3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Primary Refractory Neuroblastoma in Bone Marrow

Who this might be right for
Neuroblastoma
Memorial Sloan Kettering Cancer Center 31
Early research (Phase 1)Active Not RecruitingNCT07007117
What this trial is testing

PHOX2B PC-CAR T Cells for Relapsed Neuroblastoma

Who this might be right for
Refractory NeuroblastomaRelapsed NeuroblastomaHigh-Risk Neuroblastoma
Stephan Grupp MD PhD 38
Next Page